Reinhard Kandera
Net worth: 4 911 $ as of 2026-05-30
Net worth: 4 911 $ as of 2026-05-30
Reinhard Kandera is currently the Secretary & Director at Intercell USA, Inc., the Managing Director at Elatos GmbH, and a Director at Vaccines Holdings Sweden AB. Previously, he held positions as the Secretary & Director at Valneva Scotland Ltd., the Managing Director at VALNEVA Austria GmbH, the Chief Financial Officer & Director at HOOKIPA Pharma, Inc., the Chief Financial Officer & Head-Investor Relations at Intercell AG, and the Chief Financial Officer at Valneva SE.
Dr. Kandera obtained a doctorate degree from Vienna University of Economics & Business and a graduate degree from the University of Vienna.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HOOKIPA PHARMA INC. 0.04% | 2025-06-03 | 4,308 ( 0.04% ) | 4 911 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| IOMAI CORPORATION | Director/Board Member | - |
Elatos GmbH | Corporate Officer/Principal | 2013-11-30 |
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Develops and distributes vaccines and biological products | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| HOOA PHARPAR | Director of Finance/CFO | 2024-07-21 |
| VALNEVA SE | Director of Finance/CFO | - |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Manufactures drugs and medicines | Director of Finance/CFO | 2013-05-27 |
Valneva Austria GmbH
Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops and commercializes vaccines for infectious diseases | Corporate Officer/Principal | - |
Valneva Scotland Ltd.
Valneva Scotland Ltd. BiotechnologyHealth Technology Engages in producing encephalitis vaccine | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Manufactures drugs and medicines | Health Technology |
Vienna University of Economics & Business
Vienna University of Economics & Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vienna
University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
Valneva Scotland Ltd.
Valneva Scotland Ltd. BiotechnologyHealth Technology Engages in producing encephalitis vaccine | Health Technology |
Valneva SE
Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Valneva Austria GmbH
Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops and commercializes vaccines for infectious diseases | Commercial Services |
Elatos GmbH | |
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Develops and distributes vaccines and biological products | Health Technology |
HOOKIPA Pharma, Inc.
HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Select your edition
All financial news and data tailored to specific country editions